Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123216) titled 'Sedative Efficacy of Remimazolam Besylate for Fiberoptic Bronchoscopy and Treatment in Non-Intubated ICU Patients and Its Impact on Hemodynamic Parameters - A Prospective, Observational Clinical Study' on April 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Chengdu Third People's Hospital
Condition:
Respiratory Diseases
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-27
Target Sample Size: Observation group(Remimazolam Besylate):148;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319871...